CHP
EDIT icon

Cable Hill Partners’s Editas Medicine EDIT Stock Holding History

Cable Hill Partners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-250
Closed -$6K – 274
2019
Q1 		$6K Buy
250
+200
+400% +$4.53K ﹤0.01% 565
2018
Q4 		$1K Hold
50
– – ﹤0.01% 757
2018
Q3 		$1K Hold
50
– – ﹤0.01% 744
2018
Q2 		$2K Sell
50
-200
-80% -$7.08K ﹤0.01% 821
2018
Q1 		$8K Sell
250
-100
-29% -$3.56K ﹤0.01% 531
2017
Q4 		$12K Buy
350
+180
+106% +$4.53K 0.01% 525
2017
Q3 		$4K Hold
170
– – ﹤0.01% 810
2017
Q2 		$3K Hold
170
– – ﹤0.01% 628
2017
Q1 		$4K Hold
170
– – ﹤0.01% 572
2016
Q4 		$3K Hold
170
– – ﹤0.01% 610
2016
Q3 		$3K Hold
170
– – ﹤0.01% 650
2016
Q2 		$5K Buy
+170
New +$5.74K ﹤0.01% 498

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Cable Hill Partners's EDIT Position: Q2 2019 in Review

Cable Hill Partners sold out of Editas Medicine (EDIT) in Q2 2019, closing a stake of 250 shares — an estimated $6K sold.

Cable Hill Partners first reported a position in EDIT in Q2 2016 and held it in 12 quarters. The position peaked at $12K in Q4 2017. 193 funds tracked by Wall St. Rank hold EDIT as of Q2 2019.

  • Cable Hill Partners reported no remaining Editas Medicine position as of Q2 2019 after selling out during the quarter.
  • Cable Hill Partners sold 250 Editas Medicine shares in Q2 2019, an estimated $6K.
  • Cable Hill Partners first reported a position in Editas Medicine in Q2 2016 and held it in 12 quarters.
  • Cable Hill Partners's Editas Medicine position peaked at $12K in Q4 2017.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2019.

Based on Cable Hill Partners's 13F filing for Q2 2019, filed 6 Aug 2019.